Veradigm (NASDAQ:MDRX) Research Coverage Started at began coverage on shares of Veradigm (NASDAQ:MDRXFree Report) in a report released on Friday. The brokerage issued a hold rating on the software maker’s stock.

A number of other equities research analysts have also recently commented on the stock. Royal Bank of Canada reduced their price target on shares of Veradigm from $22.00 to $11.00 and set an outperform rating for the company in a report on Friday, January 19th. Deutsche Bank Aktiengesellschaft reaffirmed a hold rating and issued a $10.00 target price (down from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of Hold and an average target price of $11.25.

Get Our Latest Analysis on MDRX

Veradigm Price Performance

MDRX traded down $0.30 during trading on Friday, hitting $7.55. The company’s stock had a trading volume of 114,135 shares, compared to its average volume of 342,330. Veradigm has a twelve month low of $5.01 and a twelve month high of $14.09. The stock’s fifty day moving average price is $7.82 and its 200-day moving average price is $9.33.

Institutional Trading of Veradigm

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MDRX. TFO Wealth Partners LLC grew its position in Veradigm by 105,280.0% in the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after purchasing an additional 5,264 shares in the last quarter. Gladius Capital Management LP lifted its holdings in Veradigm by 135.0% during the fourth quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after acquiring an additional 3,587 shares during the period. Headlands Technologies LLC boosted its position in Veradigm by 14,907.7% in the fourth quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock worth $102,000 after purchasing an additional 9,690 shares during the last quarter. Covestor Ltd grew its stake in Veradigm by 10.3% in the 3rd quarter. Covestor Ltd now owns 10,336 shares of the software maker’s stock valued at $136,000 after purchasing an additional 966 shares during the period. Finally, Meadow Creek Wealth Advisors LLC purchased a new stake in shares of Veradigm during the 1st quarter valued at $83,000.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Recommended Stories

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with's FREE daily email newsletter.